These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Artemisinin resistance in rodent malaria--mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking. Henriques G; Martinelli A; Rodrigues L; Modrzynska K; Fawcett R; Houston DR; Borges ST; d'Alessandro U; Tinto H; Karema C; Hunt P; Cravo P Malar J; 2013 Apr; 12():118. PubMed ID: 23561245 [TBL] [Abstract][Full Text] [Related]
4. Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. Hunt P; Afonso A; Creasey A; Culleton R; Sidhu AB; Logan J; Valderramos SG; McNae I; Cheesman S; do Rosario V; Carter R; Fidock DA; Cravo P Mol Microbiol; 2007 Jul; 65(1):27-40. PubMed ID: 17581118 [TBL] [Abstract][Full Text] [Related]
5. Genomewide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine, and artemisinin in Plasmodium chabaudi malaria parasites. Borges S; Cravo P; Creasey A; Fawcett R; Modrzynska K; Rodrigues L; Martinelli A; Hunt P Antimicrob Agents Chemother; 2011 Oct; 55(10):4858-65. PubMed ID: 21709099 [TBL] [Abstract][Full Text] [Related]
6. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Afonso A; Hunt P; Cheesman S; Alves AC; Cunha CV; do Rosário V; Cravo P Antimicrob Agents Chemother; 2006 Feb; 50(2):480-9. PubMed ID: 16436700 [TBL] [Abstract][Full Text] [Related]
7. A high-coverage artificial chromosome library for the genome-wide screening of drug-resistance genes in malaria parasites. Iwanaga S; Kaneko I; Yuda M Genome Res; 2012 May; 22(5):985-92. PubMed ID: 22426943 [TBL] [Abstract][Full Text] [Related]
8. On the contribution of the rodent model Plasmodium chabaudi for understanding the genetics of drug resistance in malaria. Cravo P Parasitol Int; 2022 Dec; 91():102623. PubMed ID: 35803536 [TBL] [Abstract][Full Text] [Related]
9. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene. Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD Malar J; 2010 May; 9():135. PubMed ID: 20492669 [TBL] [Abstract][Full Text] [Related]
10. Gene synteny and chloroquine resistance in Plasmodium chabaudi. Hunt P; Martinelli A; Fawcett R; Carlton J; Carter R; Walliker D Mol Biochem Parasitol; 2004 Aug; 136(2):157-64. PubMed ID: 15478795 [TBL] [Abstract][Full Text] [Related]
11. Linkage group selection: rapid gene discovery in malaria parasites. Culleton R; Martinelli A; Hunt P; Carter R Genome Res; 2005 Jan; 15(1):92-7. PubMed ID: 15632093 [TBL] [Abstract][Full Text] [Related]
12. Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite. Rodrigues LA; Henriques G; Borges ST; Hunt P; Sanchez CP; Martinelli A; Cravo P PLoS One; 2010 Jul; 5(7):e11593. PubMed ID: 20657645 [TBL] [Abstract][Full Text] [Related]
13. Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi. Hayton K; Ranford-Cartwright LC; Walliker D Antimicrob Agents Chemother; 2002 Aug; 46(8):2482-9. PubMed ID: 12121922 [TBL] [Abstract][Full Text] [Related]
14. Virulence, drug sensitivity and transmission success in the rodent malaria, Plasmodium chabaudi. Schneider P; Bell AS; Sim DG; O'Donnell AJ; Blanford S; Paaijmans KP; Read AF; Reece SE Proc Biol Sci; 2012 Nov; 279(1747):4677-85. PubMed ID: 23015626 [TBL] [Abstract][Full Text] [Related]
15. Status of Artemisinin Resistance in Malaria Parasite Oboh MA; Ndiaye D; Antony HA; Badiane AS; Singh US; Ali NA; Bharti PK; Das A Biomed Res Int; 2018; 2018():2305062. PubMed ID: 30402465 [TBL] [Abstract][Full Text] [Related]
16. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018). Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951 [TBL] [Abstract][Full Text] [Related]
17. Experimentally Engineered Mutations in a Ubiquitin Hydrolase, UBP-1, Modulate Simwela NV; Hughes KR; Roberts AB; Rennie MT; Barrett MP; Waters AP Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340987 [TBL] [Abstract][Full Text] [Related]
18. An AFLP-based genetic linkage map of Plasmodium chabaudi chabaudi. Martinelli A; Hunt P; Fawcett R; Cravo PV; Walliker D; Carter R Malar J; 2005 Feb; 4():11. PubMed ID: 15707493 [TBL] [Abstract][Full Text] [Related]
19. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin. Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110 [TBL] [Abstract][Full Text] [Related]
20. Updates on k13 mutant alleles for artemisinin resistance in Plasmodium falciparum. Zaw MT; Emran NA; Lin Z J Microbiol Immunol Infect; 2018 Apr; 51(2):159-165. PubMed ID: 28711439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]